These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25425053)

  • 1. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
    Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
    Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.
    Khatik R; Dwivedi P; Khare P; Kansal S; Dube A; Mishra PR; Dwivedi AK
    Expert Opin Drug Deliv; 2014 May; 11(5):633-46. PubMed ID: 24606222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis.
    Chaurasia M; Singh PK; Jaiswal AK; Kumar A; Pawar VK; Dube A; Paliwal SK; Chourasia MK
    Pharm Res; 2016 Nov; 33(11):2617-29. PubMed ID: 27401407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.
    Gupta PK; Jaiswal AK; Kumar V; Verma A; Dwivedi P; Dube A; Mishra PR
    Mol Pharm; 2014 Mar; 11(3):951-63. PubMed ID: 24495144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.
    Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
    Nanomedicine (Lond); 2015; 10(7):1093-109. PubMed ID: 25929567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis.
    Singh PK; Pawar VK; Jaiswal AK; Singh Y; Srikanth CH; Chaurasia M; Bora HK; Raval K; Meher JG; Gayen JR; Dube A; Chourasia MK
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):1220-1231. PubMed ID: 28780414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis.
    Gupta PK; Asthana S; Jaiswal AK; Kumar V; Verma AK; Shukla P; Dwivedi P; Dube A; Mishra PR
    Bioconjug Chem; 2014 Jun; 25(6):1091-102. PubMed ID: 24842628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressed Macrophage Mannose Receptor Targeted Nanocapsules- Mediated Cargo Delivery Approach for Eradication of Resident Parasite: In Vitro and In Vivo Studies.
    Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
    Pharm Res; 2015 Aug; 32(8):2663-77. PubMed ID: 25715698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani.
    Tripathi P; Jaiswal AK; Dube A; Mishra PR
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):625-637. PubMed ID: 28716750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis.
    Italia JL; Kumar MN; Carter KC
    J Biomed Nanotechnol; 2012 Aug; 8(4):695-702. PubMed ID: 22852479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
    Jain V; Gupta A; Pawar VK; Asthana S; Jaiswal AK; Dube A; Chourasia MK
    Appl Biochem Biotechnol; 2014 Oct; 174(4):1309-1330. PubMed ID: 25106894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.
    Asthana S; Jaiswal AK; Gupta PK; Pawar VK; Dube A; Chourasia MK
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1714-22. PubMed ID: 23357762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.
    Gupta S; Dube A; Vyas SP
    J Drug Target; 2007 Jul; 15(6):437-44. PubMed ID: 17613662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
    Shahnaz G; Edagwa BJ; McMillan J; Akhtar S; Raza A; Qureshi NA; Yasinzai M; Gendelman HE
    Nanomedicine (Lond); 2017 Jan; 12(2):99-115. PubMed ID: 27879160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.
    Prajapati VK; Awasthi K; Gautam S; Yadav TP; Rai M; Srivastava ON; Sundar S
    J Antimicrob Chemother; 2011 Apr; 66(4):874-9. PubMed ID: 21393222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presenting cells targeting and stimulation potential of lipoteichoic acid functionalized lipo-polymerosome: a chemo-immunotherapeutic approach against intracellular infectious disease.
    Gupta PK; Jaiswal AK; Asthana S; Dube A; Mishra PR
    Biomacromolecules; 2015 Apr; 16(4):1073-87. PubMed ID: 25671728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th-1 biased immunomodulation and synergistic antileishmanial activity of stable cationic lipid-polymer hybrid nanoparticle: biodistribution and toxicity assessment of encapsulated amphotericin B.
    Asthana S; Jaiswal AK; Gupta PK; Dube A; Chourasia MK
    Eur J Pharm Biopharm; 2015 Jan; 89():62-73. PubMed ID: 25477079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of 4-sulfated N-acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis.
    Tripathi P; Dwivedi P; Khatik R; Jaiswal AK; Dube A; Shukla P; Mishra PR
    Colloids Surf B Biointerfaces; 2015 Dec; 136():150-9. PubMed ID: 26381698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies.
    Mudavath SL; Talat M; Rai M; Srivastava ON; Sundar S
    Drug Des Devel Ther; 2014; 8():1235-47. PubMed ID: 25214767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani.
    Kumar R; Sahoo GC; Pandey K; Das V; Das P
    Drug Deliv; 2015 May; 22(3):383-8. PubMed ID: 24601828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.